Day 547 | Join us for this week’s “What’s in the News?” There’s some suing going on….will that affect our shots’ prices? Plus info on weight loss genes and Eli Lilly Mounjaro and Zepbound availability!!
John’s 2 article links: https://www.nbcnews.com/health/health-news/hungry-gut-gene-variant-may-indicate-wegovy-will-work-weight-loss-rcna153034 AND https://time.com/6979498/will-weight-loss-drugs-work-for-me/
Most Popular Website Videos
Oral Tirzepatide: Is the Pill or Shot Better? https://www.amydenaeweightloss.com/oral-tirzepatide-is-the-pill-or-shot-better/
It’s not a one-size-fits-all medicine! https://www.amydenaeweightloss.com/its-not-a-one-size-fits-all-medicine/
Remember these 4 Things as you’re Losing Weight! https://www.amydenaeweightloss.com/remember-these-4-things-as-youre-losing-weight/
Who Am I?
My name is Amy Denae and I tried for over 30 years to get healthy. That changed on December 1, 2022. Thanks Mounjaro! Since Day 1, I have shared my journey on this amazing life changing medicine. I love researching and bringing relevant topics to our Community Website! Thanks for watching! Much Love, amy2.0
Amy’s Weight Loss 5’8” *Goal 158*
MONTH 1 (Start 218, End 195, 23 lbs lost, BMI 35)
MONTH 2 (Start 195, End 184, 11 lbs lost)
MONTH 3 (Start 184, End 175, 9 lbs lost, BMI 29)
MONTH 4 (Start 175, End 170, 5 lbs lost, BMI 27)
MONTH 5 (Start 170, End 167, 3 lbs lost)
MONTH 6 (Start 167, End 158, 9 lbs lost) HIT GOAL WEIGHT!
MONTH 7 GOAL MET! 158 lbs Maintenance Begins
MONTHS 8-18 MAINTENANCE! 145-155 lbs maintained for 76 WEEKS!!
Eli Lilly: The Expanding Influence in Pharmaceuticals
Eli Lilly, a prominent pharmaceutical company, is making headlines with significant developments in drug pricing and production expansion. Recently, the company has been involved in several high-profile events that highlight its role in the pharmaceutical industry and its impact on consumers.
Eli Lilly and the Cost of Insulin
One of the major issues involving Eli Lilly is the cost of insulin. The Attorney General of Oklahoma has filed a lawsuit against Eli Lilly, accusing the company of unlawfully inflating the prices of insulin. This lawsuit is part of a broader concern about the affordability of life-saving medications. Eli Lilly has responded by highlighting its efforts to reduce insulin prices, including a 70% price cut and a cap of $35 a month for insulin users .
The Broader Context of Drug Pricing
The issue of drug pricing is not limited to insulin. There has been increasing scrutiny on the cost of other medications, such as Mounjaro and Wegovy, which are used for weight management. These drugs, which can cost over $1,000 a month, have been the subject of debates about their affordability and accessibility. High-profile figures like Bernie Sanders have pressured pharmaceutical companies, including Novo Nordisk, to justify their pricing structures and production costs .
Research and Innovation at Eli Lilly
Eli Lilly is not just facing legal and consumer pressures; it is also heavily investing in research and innovation. The company is expanding its production capabilities to meet the growing demand for its products. Eli Lilly announced a $9 billion investment in its campus in Lebanon, Indiana, which is the largest in its 148-year history. This expansion is expected to create over 5,000 construction jobs and 200 long-term positions, highlighting the company’s commitment to growth and innovation .
The Role of Genetics in Drug Efficacy
Recent studies have also brought attention to the genetic factors influencing drug efficacy. For example, a study involving semaglutide, a drug used for weight loss, found that individuals with a specific gene, referred to as the “Hungry Gut” gene, responded better to the medication. This gene causes the gut to empty quickly, making individuals feel hungry soon after eating. Semaglutide helps by slowing down the gut’s emptying process, making individuals feel fuller for longer. This finding could influence how drugs are prescribed in the future, potentially making treatments more personalized .
Eli Lilly’s Future Prospects
The expansion of Eli Lilly’s production facilities and its significant investment in research indicate a promising future for the company. However, it must navigate the complex landscape of drug pricing and regulatory scrutiny. As it continues to innovate and grow, Eli Lilly’s actions will likely remain under the public and legal microscope.
For more information on Eli Lilly’s initiatives and developments, you can visit Eli Lilly’s official website .
You need to login in order to like this post.
2 thoughts on “Eli Lilly: Making More MJ!”
Interesting study you shared! I’d love to read the articles myself so if you could post the links, that would be great. A question that came to mind while you were describing each of the study groups is: how were those categories determined? Did study participants report themselves as “hungry brain” or “emotionally hungry” or did they fill out surveys and the researchers assigned them or what? It seemed like there were so many variables in this study. Anyhow, thanks for bringing this information to us! I always enjoy these videos.
Oh yes Edie, those are great follow-up questions! I have also continued to think about some things he said in the last couple days. I think this is why this website’s theme never stops being fascinating to me. There are always so many things to see and read and learn! Never boring 😉 I added the two links to the description. Thanks so much!